Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients

Clinical and Experimental Immunology

Volumn 123, Issue 1, 2001, Pages 140-146

  Schrijver, I A ^a   De Man, Y A ^a   Melief, M J ^a   Van Laar, J M ^b   Markusse, H M ^c   Klasen, I S ^d   Hazenberg, M P ^a   Laman, J D ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Zuiderziekenhuis   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Antibodies; Gram positive bacteria; Gut flora; Peptidoglycan; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PEPTIDOGLYCAN POLYSACCHARIDE; PEPTIDOGLYCAN POLYSACCHARIDE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FECES; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPTIDOGLYCAN; SEX FACTORS; SYNOVIAL FLUID;

EID: 0035144937     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01419.x     Document Type: Article

References (45)

1. Infectious agents as triggers of reactive arthritis
2. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis
3. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
4. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis
5. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis
6. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis
7. Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter's disease
8. Review article: Bone and joint diseases in inflammatory bowel disease
9. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history
10. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immuno pathologies
11. Intestinal flora bacteria and arthritis: Why the joint?
12. The involvement of the gut in the pathogenesis of inflammatory synovitis
13. Intestinal bacteria and rheumatic disease
14. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans
15. Peptidoglycan types of bacterial cell walls and their taxonomic implications
16. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn's disease
17. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats
18. Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora
19. Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats
20. Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells
21. Detection of muramic acid in a carbohydrate fraction of human spleen
22. Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells
23. Role of cytokines in rheumatoid arthritis
24. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease
25. Serum antibodies to peptidoglycan-polysaccharide complexes from the anaerobic intestinal flora in patients with Crohn's disease
26. Biology and clinical significance of peptidoglycan antibody response in staphylococcal infections
27. Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus
28. High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides
29. Detection of antibodies against streptococcal peptidoglycan and the peptide subunit (synthetic tetra-D-alanyl-bovine serum albumin complex) in rheumatic diseases
30. Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease
31. Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis
32. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
33. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
34. New international reference preparation for proteins in human serum (RPPHS)
35. The influence of sex on the phenotype of rheumatoid arthritis
36. Epidemiology of rheumatoid arthritis: Update
37. Permeability of rheumatoid and normal human synovium to specific plasma proteins
38. Review article: Homing of mucosal immune cells - A possible connection between intestinal and articular inflammation
39. Adhesion of rheumatoid lymphocytes to mucosal endothelium: The gut revisited
40. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: Dissection of the molecular mechanisms
41. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track
42. Analysis of in vitro polyclonal B cell differentiation responses to bacterial peptidoglycan and pokeweed mitogen in rheumatoid arthritis
43. Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis
44. Regional specialization in the mucosal immune system: What happens in the microcompartments?
45. Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum